Nora Khaldi, Ph.D., Nuritas, Ltd.

Nora Khaldi, Ph.D. Dr. Nora Khaldi is the founder and chief scientific officer of Nuritas, a disruptive drug discovery company leveraging the power of artificial intelligence to discover entirely new peptide-based therapeutics in areas of unmet medical need. As an early visionary and pioneer of AI for discovery, Dr. Khaldi, with an interdisciplinary academic background in mathematics, molecular evolution, computational genomics and bioinformatics established Nuritas in 2014 with a mission to establish a hybrid TechBio company to identify new putative drugs from within natural and safe sources- paving the path towards safer, less costly and more sustainable drug discovery and development. In 2017, Dr. Khaldi was named Woman of the Decade in Business and Leadership at the Women Economic Forum (WEF) European Union Event and received the Rising Star prize form the Tech Excellence Awards. Dr. Khaldi continues to lead the Nuritas team in their goal of reaching billions of people with their life-changing discoveries, working with global leaders such as BASF, Nestle and other thought leaders.

Session

4:25 PM - 5:00 PM

Innovation Spotlight Changemaker Presentations

The Innovation Spotlight Presentation program features six changemaker speakers along with moderator Travis McCready, President & CEO of Massachusetts Life Sciences Center. Each speaker presents a concise and fast-paced 5-minute presentation that will introduce you to an innovative way of solving a problem, a new technology or tool, or a transformative approach to solving common issues facing biopharma companies today. Immediately following the spotlight presentations, attendees can meet with these innovative companies in a relaxed atmosphere during the evening reception.

Moderator

Changemaker Presenters

  • Kyle Martin Flickinger

    Kyle Martin Flickinger Vice President Bio Pharmaceutical Solution Strategy Deep Lens

    • Speed to Hope – What does confirmation of diagnosis in precision oncology really imply?
    • The use of digital pathology case management workflow and AI to support clinical research as a care option:
        – What is the need? What are the solutions? Where is Digital pathology heading?

     

  • Tim Gardner, Ph.D.

    Tim Gardner, Ph.D. Founder/CEO Riffyn

    Lab data to machine learning in 30 seconds

    • Lab challenge: data heterogeneity, silos, constant change in R&D
    • Data challenge: systems lack structure, flexibility, accessibility
    • Solution: evolvable “scientific blueprints”: bridge silos with clean & connected data

Download Latest Agenda